• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

Pfizer Recalls Children’s Advil Product After Its Measuring Cup Confused Milliliters With Teaspoons

By
Glenn Fleishman
Glenn Fleishman
By
Glenn Fleishman
Glenn Fleishman
August 27, 2018, 8:00 PM ET
Children's Advil Cold medicine and dosage chart.
Children's Advil Cold medicine and dosage chart. (Photo by Anacleto Rapping/Los Angeles Times via Getty Images)Anacleto Rapping—LA Times via Getty Images

Pfizer has recalled a specific production run of its Children’s Advil Suspension Bubble Gum Flavored anti-inflammation medicine in a 4 fl. oz. bottle. The instructions for the medication are noted in milliliters (mL), but the included measuring cup notes only teaspoons.

This particular lot was distributed across the U.S. in May and June 2018, and is marked R51129 on the label, with an expiration date of 11/20. The UPC number is 3-0573-0207-30-0.

The company issued a voluntary recall out of concerns of “a chance of being associated with potential overdose,” it said in a statement. One teaspoon contains five times as much volume as 1 mL. The Food and Drug Administration isn’t involved, but Pfizer said they were informed.

There’s no fault with the medication itself, however.

If a parent relied on the measuring cup without noticing the cup was denoted only in teaspoons, they could administer a dose to a child that exceeds safety limits, and would be high enough to cause an ibuprofen overdose. An overdose can lead to symptoms like nausea and vomiting, as well as drowsiness, blurred vision, and other symptoms.

No information was immediately available about obtaining refunds.

Pfizer offers information by phone and can accept adverse health reports at 1-800-882-3845 between 9 a.m. and 5 p.m. Eastern Time from Monday to Friday.

About the Author
By Glenn Fleishman
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.